ACM
LKFT

Aquilo Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Aquilo Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-142,340
Closed -$9.81M – 15
2021
Q2 		$9.81M Buy
142,340
+25,617
+22% +$1.95M 2.55% 13
2021
Q1 		$9M Buy
116,723
+46,734
+67% +$4.31M 1.63% 15
2020
Q4 		$6.93M Buy
69,989
+37,455
+115% +$4.58M 1.44% 14
2020
Q3 		$4.62M Sell
32,534
-11,700
-26% -$1.95M 0.49% 14
2020
Q2 		$8.73M Hold
44,234
– – 1.76% 12
2020
Q1 		$8.67M Sell
44,234
-27,733
-39% -$5.97M 3.38% 13
2019
Q4 		$14.9M Buy
71,967
+15,127
+27% +$2.8M 5.59% 6
2019
Q3 		$8.68M Buy
56,840
+10,000
+21% +$1.64M 6.11% 8
2019
Q2 		$6.04M Buy
46,840
+25,000
+114% +$2.97M 2.1% 13
2019
Q1 		$2.57M Sell
21,840
-14,080
-39% -$1.42M 1.14% 12
2018
Q4 		$3.29M Buy
35,920
+4,600
+15% +$466K 1.59% 12
2018
Q3 		$3.52M Sell
31,320
-34,730
-53% -$3.67M 1.47% 11
2018
Q2 		$6.09M Buy
+66,050
New +$6.41M 5.02% 8

Other funds holding LKFT

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Aquilo Capital Management's LKFT Position: Q3 2021 in Review

Aquilo Capital Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2021, closing a stake of 142,340 shares — an estimated $9.81M sold.

Aquilo Capital Management first reported a position in LKFT in Q2 2018 and held it in 13 quarters. The position peaked at $14.9M in Q4 2019. 81 funds tracked by Wall St. Rank hold LKFT as of Q3 2021.

  • Aquilo Capital Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Aquilo Capital Management sold 142,340 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2021, an estimated $9.81M.
  • Aquilo Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2018 and held it in 13 quarters.
  • Aquilo Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $14.9M in Q4 2019.
  • 81 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2021.

Based on Aquilo Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.